June 22, 2022

FDA approves dabrafenib plus trametinib for BRAF V600E-mutated tumors based on data from NCI-MATCH

June 1, 2022

Precision medicine clinical trials: A conversation between Peter Oโ€™Dwyer and Lale Kostakoglu

March 8, 2022

JAMA Oncology publishes TAILORx data showing racial and neighborhood disparities in breast cancer

March 1, 2022

FDA notes the NCI-MATCH trial in its release of new guidance on master protocols and expansion cohorts

April 26, 2021

Press Release: 12 open arms in NCI-MATCH treatment trial await patients with advanced or rare cancers

October 13, 2020

Press Release: Genomic study of 6000 NCI-MATCH cancer patients leads to new clinical trial benchmarks

January 7, 2020

Press Release: NCI-MATCH finds that T-DM1 shows promising activity in salivary gland cancer

December 19, 2019

Press Release: NCI-MATCH finds promising signal for nivolumab beyond colorectal cancer

June 3, 2019

Press Release: NCI-MATCH trial finds the combination of dabrafenib and trametinib effective

ECOG-ACRIN Cancer Research Group